References
- Choi EC, Kim ES, Kim JS, Hong WP. Surgical teatment of squamous cell carcinoma of the tonsil. Korean J Otolaryngol. 1996;39:57-68.
- O'Brien CJ, Carter RL, Soo KC. Invasion of the mandible by squamous carcinomas of the oral cavity and oropharynx. Head Neck Surg. 1986;8:247-256.
- Morani AC, Eisbruch A, Carey TE, et al. Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies. J Comput Assist Tomogr. 2013;37(3):343-345. https://doi.org/10.1097/RCT.0b013e318282d7c3
- Weissman JL, Holliday RA. Hypopharynx. In: Som PM, Curtin HD, editors. Head and Neck Imaging. 3rd ed. St. Louis: Mosby; 1996.
- Pfister DG, Su YB, Kraus DH, et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combinedmodality paradigm. J Clin Oncol. 2006;24:1072-1078. https://doi.org/10.1200/JCO.2004.00.1792
- Toledano I, Graff P, Serre A, et al. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol J Eur Soc Therapeutic Radiol Oncol. 2012;103:57-62. https://doi.org/10.1016/j.radonc.2011.12.010
- Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35. https://doi.org/10.1056/NEJMoa0912217
- NCCN clinical practice guidelines in oncology, Head and Neck Cancer version 1.2015.